Lake Point Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$5K Hold
77
﹤0.01% 226
2022
Q1
$5K Hold
77
﹤0.01% 240
2021
Q4
$6K Sell
77
-128
-62% -$8.82K ﹤0.01% 239
2021
Q3
$14K Hold
205
0.01% 136
2021
Q2
$14K Buy
+205
New +$13.7K 0.01% 147
2020
Q1
$48K Buy
647
+570
+740% +$39.4K 0.04% 45
2019
Q4
$5K Buy
+77
New +$5.01K ﹤0.01% 367
2019
Q2
$5K Hold
77
﹤0.01% 422
2019
Q1
$5K Sell
77
-69
-47% -$4.59K ﹤0.01% 422
2018
Q4
$9K Buy
+146
New +$10.2K ﹤0.01% 479

Other funds holding GILD

Lake Point Wealth Management's GILD Position: Q2 2022 in Review

Lake Point Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2022 at 77 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #226.

Lake Point Wealth Management first reported a position in GILD in Q4 2018 and has held it in 10 quarters since. The position peaked at $48K in Q1 2020. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • Lake Point Wealth Management held 77 shares of Gilead Sciences worth $5K as of Q2 2022.
  • Lake Point Wealth Management left its Gilead Sciences share count unchanged in Q2 2022.
  • Gilead Sciences made up ﹤0.01% of Lake Point Wealth Management's portfolio in Q2 2022, its #226 holding.
  • Lake Point Wealth Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 10 quarters since.
  • Lake Point Wealth Management's Gilead Sciences position peaked at $48K in Q1 2020.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Lake Point Wealth Management's 13F filing for Q2 2022, filed 19 Jul 2022.